Application of Artificial Intelligence in the Management of Pancreatic Cystic Lesions
Open Access
- 14 June 2022
- journal article
- review article
- Published by MDPI AG in Biomimetics
- Vol. 7 (2) , 79
Abstract
The rate of incidentally detected pancreatic cystic lesions (PCLs) has increased over the past decade and was recently reported at 8%. These lesions pose a unique challenge, as each subtype of PCL carries a different risk of malignant transformation, ranging from 0% (pancreatic pseudocyst) to 34–68% (main duct intraductal papillary mucinous neoplasm). It is imperative to correctly risk-stratify the malignant potential of these lesions in order to provide the correct care course for the patient, ranging from monitoring to surgical intervention. Even with the multiplicity of guidelines (i.e., the American Gastroenterology Association guidelines and Fukuoka/International Consensus guidelines) and multitude of diagnostic information, risk stratification of PCLs falls short. Studies have reported that 25–64% of patients undergoing PCL resection have pancreatic cysts with no malignant potential, and up to 78% of mucin-producing cysts resected harbor no malignant potential on pathological evaluation. Clinicians are now incorporating artificial intelligence technology to aid in the management of these difficult lesions. This review article focuses on advancements in artificial intelligence within digital pathomics, radiomics, and genomics as they apply to the diagnosis and risk stratification of PCLs.Keywords
This publication has 83 references indexed in Scilit:
- A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidanceEndoscopy, 2013
- Branch Duct Intraductal Papillary Mucinous NeoplasmsAnnals of Surgery, 2013
- Pancreatic neuroendocrine tumors: biology, diagnosis,and treatmentChinese Journal of Cancer, 2013
- Pancreatic Neuroendocrine Tumor With Cystlike Changes: Evaluation With MDCTAmerican Journal of Roentgenology, 2013
- 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General HospitalSurgery, 2012
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreasPancreatology, 2012
- Efficacy of an Artificial Neural Network–Based Approach to Endoscopic Ultrasound Elastography in Diagnosis of Focal Pancreatic MassesClinical Gastroenterology and Hepatology, 2012
- Cystic Lesions of the Pancreas: Changes in the Presentation and Management of 1,424 Patients at a Single Institution over a 15-Year Time PeriodJournal of the American College of Surgeons, 2011
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- Incidence of benign inflammatory disease in patients undergoing Whipple procedure for clinically suspected carcinoma: a single-institution experienceThe American Journal of Surgery, 2006